|
Market Cap (25-Jun) $27,342,400 (1,032nd) |
Close (30-Jun) $0.008 |
Volume (30-Jun) 285,280 |
Shortsold (12-Dec) 6,497 (0.00%) (681st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.09 |
EX1 released this announcement to the ASX on 4 January 2021, 11:23. The announcement is not marked as price sensitive, and is 3 page(s) in length and 228.29kb in size.
You can view all announcements from EX1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, EX1 was 0.011% short sold according to ASIC data. It was ranked the 588th most shorted stock on the ASX. It remains ranked 681st as of the latest reported data (12 December 2022).
| Other Recent Announcements from EX1 | |
|---|---|
| Initial Director's Interest Notice - MD | 22 June 2023, 11:52 |
| Change of Director's Interest Notice - CB | 22 June 2023, 11:51 |
| Final Director's Interest Notice - JW | 22 June 2023, 11:50 |
| Lapse of Performance Rights | 4 January 2021, 11:23 |
| Response to ASX Price and Volume Query | 30 December 2020, 12:28 |
| Change of Director's Interest Notice | 23 December 2020, 13:09 |
| Shareholder Update | 22 December 2020, 8:44 |
You must be logged in to post a reply.
Exopharm 